Financial Consulate, Inc Johnson & Johnson Transaction History

Financial Consulate, Inc

$324 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$151.05 - $180.26 $95,161 - $113,563	-630 Reduced 16.02%	3,303 $511,000
Q4 2022 Jan 11, 2023	SELL	$160.2 - $179.79 $4,806 - $5,393	-30 Reduced 0.76%	3,933 $0
Q2 2022 Jul 19, 2022	SELL	$168.19 - $186.01 $255,480 - $282,549	-1,519 Reduced 27.71%	3,963 $703,000
Q1 2022 Apr 28, 2022	SELL	$158.14 - $179.59 $37,795 - $42,922	-239 Reduced 4.18%	5,482 $972,000
Q4 2021 Feb 07, 2022	BUY	$155.93 - $173.01 $125,523 - $139,273	805 Added 16.38%	5,721 $979,000
Q3 2021 Oct 19, 2021	SELL	$161.5 - $179.47 $32,138 - $35,714	-199 Reduced 3.89%	4,916 $794,000
Q1 2021 Apr 19, 2021	SELL	$153.07 - $170.48 $22,654 - $25,231	-148 Reduced 2.81%	5,115 $841,000
Q4 2020 Jan 29, 2021	BUY	$137.11 - $157.38 $58,271 - $66,886	425 Added 8.78%	5,263 $828,000
Q3 2020 Oct 20, 2020	SELL	$140.38 - $153.83 $5,615 - $6,153	-40 Reduced 0.82%	4,838 $720,000
Q2 2020 Jul 22, 2020	BUY	$128.81 - $155.51 $129,196 - $155,976	1,003 Added 25.88%	4,878 $686,000
Q1 2020 Apr 29, 2020	BUY	$111.14 - $153.99 $50,346 - $69,757	453 Added 13.24%	3,875 $508,000
Q3 2019 Oct 16, 2019	BUY	$126.95 - $142.14 $59,031 - $66,095	465 Added 15.73%	3,422 $443,000
Q2 2019 Jul 24, 2019	BUY	$131.15 - $144.24 $26,230 - $28,848	200 Added 7.25%	2,957 $412,000
Q1 2019 May 01, 2019	SELL	$125.72 - $139.79 $12,697 - $14,118	-101 Reduced 3.53%	2,757 $385,000
Q3 2018 Oct 29, 2018	SELL	$121.58 - $142.88 $25,531 - $30,004	-210 Reduced 6.84%	2,858 $395,000
Q2 2018 Jul 27, 2018	BUY	$119.4 - $131.76 $51,342 - $56,656	430 Added 16.3%	3,068 $372,000
Q1 2018 Apr 16, 2018	BUY	$125.1 - $148.14 $15,137 - $17,924	121 Added 4.81%	2,638 $338,000
Q3 2017 Oct 19, 2017	BUY	$129.47 - $135.38 $325,875 - $340,751	2,517	2,517 $327,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Consulate, Inc with notifications on news.

Account